Eu Yan Sang Hong Kong

Last update: December 21, 2020

Hong Kong Its 2 main executives

Create an alert
to follow the executive moves at Eu Yan Sang Hong Kong.

Most searched biographies at Eu Yan Sang Hong Kong

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).

Other contacts in the Pharmaceuticals industry

Learn more about the Pharmaceuticals industry >

Latest news about Eu Yan Sang Hong Kong

Eu Yan Sang Hong Kong on Wikipedia, Google News & Yahoo Finance

Eu Yan Sang Hong Kong on LinkedIn, Twitter & YouTube

Eu Yan Sang Hong Kong has 2,035 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland). Eu Yan Sang Hong Kong is owned by Eu Yan Sang International.

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.